Posted BY: | NwoReport
In a surprising turn of events, the Centers for Disease Control and Prevention (CDC) has acknowledged that individuals who have received the COVID-19 vaccine may be more susceptible to infection with the new BA.2.86 Covid variant. This revelation comes when concerns about the variant and the potential for another lockdown and booster rollout are looming.
The CDC’s ‘Risk Assessment Summary for SARS CoV-2 Sublineage BA.2.86,’ published recently, states that this new variant “may be more capable of causing infection in people who have previously had COVID-19 or received COVID-19 vaccines.” This admission raises questions about the effectiveness of the vaccine, as the very organization that previously dismissed such claims as ‘disinformation’ is now acknowledging increased infection risk among the vaccinated.
Trending: Shocking Discovery: Fani Willis Allegedly Connected to Large-Scale Election Fraud and Money Laundering Operation
Despite this revelation, the CDC maintains that the upcoming vaccines will effectively reduce severe disease and hospitalization. However, they admit that scientists are still evaluating the effectiveness of these new vaccines, raising concerns about rushed development without proper testing.
The CDC’s assessment also notes that existing tests and medications used to treat COVID-19 appear effective against this variant. There is currently no evidence to suggest that the BA.2.86 variant causes more severe illness, though this assessment may change as more data becomes available. Updated vaccines are expected to be known as early as mid-September.
This admission by the CDC follows a study conducted by the Cleveland Clinic, which found that more COVID-19 vaccine doses received increased the risk of infection with the virus. The study, published in Open Forum Infectious Diseases, was peer-reviewed and conducted within the healthcare system, emphasizing the need to maintain an effective workforce during the pandemic.
In conclusion, the CDC’s acknowledgment of increased infection risk among the vaccinated with the new Covid variant raises concerns about vaccine effectiveness and the need for further research. It remains to be seen how this revelation will impact future vaccination strategies and public health measures.
